Health Industry

Latest KFF Health News Stories

Can A Community Hospital Stay True To Its Mission After Sale To Large Corporation?

KFF Health News Original

After 130 years as a nonprofit with deep roots in western North Carolina, Mission Health announced in March that it was seeking to be bought by HCA Healthcare, the nation’s largest for-profit hospital chain.

Podcast: KHN’s ‘What The Health?’ Drug Prices And Unicorns

KFF Health News Original

In this episode of KHN’s “What the Health?” Julie Rovner of Kaiser Health News, Margot Sanger-Katz of The New York Times, Joanne Kenen of Politico, and Erin Mershon of Stat News discuss a series of health policy court decisions on everything from prescription drug discounts to soda taxes. Plus, Rovner, interviews health care futurist and consultant Jeff Goldsmith.

Insurers Fall Short In Catching And Reporting Medicaid Fraud, Inspectors Find

KFF Health News Original

Medicaid has struggled for years with poor oversight and billions lost to improper payments. A new report finds that despite their fraud-fighting rhetoric, Medicaid managed-care companies are not as rigorous as they should be in ensuring the integrity of the Medicaid payment system.

Podcast: KHN’s ‘What The Health?’ Whither Work Requirements?

KFF Health News Original

In this episode of KHN’s “What the Health?” Julie Rovner of Kaiser Health News, Joanne Kenen of Politico, Stephanie Armour of The Wall Street Journal and Anna Edney of Bloomberg News discuss the latest enrollment numbers for the Affordable Care Act, Medicaid work requirements in Kentucky and President Donald Trump’s proposed government reorganization plan. Plus, for extra credit, the panelists recommend their favorite health stories of the week.

Vulnerable Rural Hospitals Face Quandaries Over Questionable Billing Schemes

KFF Health News Original

Two Missouri hospitals handed over their operations to a private company that has vastly increased the money the hospitals bring in through their laboratories, even though the lab tests are not done on-site.

Out-Of-Pocket Costs Put HIV Prevention Drug Out Of Reach For Many At Risk

KFF Health News Original

It’s getting increasingly difficult for patients to afford Truvada, also known as pre-exposure prophylaxis, or PrEP, because of the drug’s high price and insurance company efforts to restrict the use of coupons that shield patients from it.